Disease | pulmonary hypertension |
Phenotype | C0085786|idiopathic interstitial pneumonia |
Sentences | 4 |
PubMedID- 24937643 | Rationale: pulmonary hypertension (ph) associated with fibrotic idiopathic interstitial pneumonia (iip; idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia) confers important additional morbidity and mortality. |
PubMedID- 26583148 | The more recent bphit (bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia) trial which evaluated the safety and clinical efficacy of bosentan in patients with ph and fibrotic idiopathic interstitial pneumonia revealed no demonstrable difference in symptoms, functional capacity, or pulmonary hemodynamics over a 16-week period [87]. |
PubMedID- 20113909 | Results: the prevalence of pulmonary hypertension in patients with idiopathic interstitial pneumonia was 29% vs 64% in patients with connective tissue disease-interstitial pneumonia (p = 0.013). |
PubMedID- 22171483 | [relationship between combined emphysema, pulmonary hypertension and %fev1 in patients with idiopathic interstitial pneumonia]. |
Page: 1